Mankind Pharma Ltd. has achieved a significant milestone as its Unit-II manufacturing facility received the prestigious British Safety Council International Safety Awards 2026, recognizing the organization’s unwavering commitment to workplace health, safety, and employee well-being.
The award celebrates Mankind Pharma’s robust safety culture, implementation of best-in-class safety practices, and continuous efforts to maintain a secure and healthy working environment across its operations. The recognition highlights the company’s proactive approach to risk management, employee training, hazard prevention, and operational excellence.
In addition to securing the Best in Sector (Manufacturing – Pharmaceuticals/Healthcare) Award, the facility was also honored with a Distinction Award, placing it among the top-performing organizations globally in safety management.
This achievement reflects Mankind Pharma’s dedication to fostering a safety-first culture while maintaining high standards of quality and productivity. The recognition further strengthens the company’s reputation as a responsible and people-centric leader in the pharmaceutical industry.
